Herborium Group, Inc. revised revenue guidance for 2013. For the period, the company expected to upgrade its expected revenues projections for 2013 discussed in the Press Release of October 15, 2012. End of 2012 sales results for AcnEase(r), Herborium's one of a kind Botanical Therapeutic(r) for acne, and AcnEase(r) performance in the two first months of the First Quarter of 2013, show a consistent growth of over 20% per quarter, therefore allowing to expect direct sales revenues from the product to more than double in the present year.

This growth should consequently increase the expected total revenues of the Company to exceed seven figures. Worldwide investor awareness campaign to increase investor value resulted from this progress is to start immediately.